Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
berrybck,
"rager does nothing to someone who calls me gay once and stupid twice"
If you would read the general board guidelines in the ibox.
you would clearly note this...
"please feel free to "PM" one of the moderators since we can't possibly catch every post."
Did you PM one of the moderators so we could remove a personal attack? or are we really expected to read every single line of every post?
This is a must read...
from ibox...
Some general board guidelines
* Please keep in mind that this is a stock specific board and is limited to discussions relating to SLJB only.
* No profanity/vulgarity
* Please do not post in all CAPS.
* If posting any article relating to SLJB, please cut and paste the article along with the link - do not just post the link.
* Open discussions both positive and negative are welcome providing the information posted isn't slanderous and can be backed up or is followed by an "imo".
* If you find spam on the board and don't see it deleted, please feel free to "PM" one of the moderators since we can't possibly catch every post.
* For more info, Investors Hub Terms of Use
http://www.investorshub.com/boards/complex_terms.asp
None of your business, keep up your antics and you are joining him.
NO because you are being disruptive.
mikeyrags, take your crap elsewhere...TIA
GZFX4ME,
I am watching that it does not become personal attacks.
I 2 wish they would get back to talking about what matters.
and of course when one answers a basher, he becomes the basher.
Guide for Stock-Specific and Free Zone Board Moderators
(These boards can be posted on by any registered free or paid member of the site.)
Note: When managing one of these boards, you have six reasons to choose from when deciding whether or not a post should be removed:
Duplicate – an accidental duplicate post by a member
Personal Attack – when someone attacks a person, with name calling, or relating to the messenger and not the message.
Spam – a message that is being posted promoting other sites, stock-related or not, that has no use in the discussion (for example, if your board is about Ford Motors, a link promoting amazing returns running a home-based business is worthless to the discussion).
Vulgarity – cursing of any kind unacceptable on your board
Violation of Privacy – posting of any personal identifiable information (email, real name, phone, address, etc)
Threat – someone threatening another member in some fashion
EMXC - Gold Rush Network Releases the Financial Spider Browser
Thursday August 24, 10:33 am ET
SPRINGFIELD, TN--(MARKET WIRE)--Aug 24, 2006 -- Gold Rush. Investment Corp, a company partly owned by eMax Holdings Corporation (Other OTC:EMXC.PK - News) www.emaxcorp.com, announces the release of the Financial Spider Browser and it can be found at http://www.goldrushnetwork.com. The Financial Spider Browser was built by Spider Technologies, Inc., www.spidertechnologies.net
The Spider Browser allows traders and market enthusiasts to keep their market information in their browser as they continue to visit other websites. The Spider Browser has many features built right in: Faith the Artificial Intelligent Agent, Gold Rush Radio Player, an editable ticker streamer, market news, client profiling and much more.
With the Spider Browser there is nothing to install, update, and no additional resources are required other than the browser. It automatic updates and has the ability to bring instant information about profiled clients to our users.
Michael Reynolds, President of the Gold Rush Network, www.goldrushnetwork.com, a division of Gold Rush Investments Corp., stated, "Now you can have your stock market tools and surf the net too. In addition, ask Faith any question regarding the financial markets or other information you would like to know."
About Gold Rush Network
The Gold Rush Network is a financial network forged of some the most qualified firms and individuals in the Financial Community. Gold Rush Investments Corporation's Financial Division will continue to develop, market, and operate many financial portals, search engines, browser and security technologies, and many other products and services related to the financial industry.
About Spider Technologies, Inc.
Spider Technologies, Inc., http://www.spidertechnologies.net, is a cutting-edge, high-tech software development company focusing on internet, new digital media and IT industries.
About eMax Holdings Corp.
eMax Holdings Corp., http://www.emaxcorp.com, is a diversified holding company investing in multimedia, entertainment, communication, broadcasting, IT, software development, real estate and finance industries. http://www.preferredinvestor.com/EMXC/profile.html
This release may contain forward-looking statements that involve risks and uncertainties, including, without limitation, acceptance of the company's products, increased levels of competition, product and technological changes, the company's dependence upon financing and third-party suppliers, and other risks detailed from time to time in the company's federal filings, annual report, offering memorandum or prospectus. Specifications are subject to change without notice.
Contact:
Contact:
Gold Rush Network
Michael Reynolds
615-384-5005
http://www.goldrushnetwork.com
info@goldrushnetwork.com
http://www.spidertechnologies.net
--------------------------------------------------------------------------------
Source: eMax Holdings Corp.
Market Regulation Services - Trading Halt - ECU Silver Mining Inc. - ECU
Thursday August 24, 9:14 am ET
VANCOUVER, Aug. 24 /CNW/ - The following issues have been halted by Market Regulation Services (RS):
Issuer Name: ECU Silver Mining Inc.
TSXV Ticker Symbol: ECU
Time of Halt: 9:02 EST
Reason for Halt: Pending News
For further information
Market Regulation Services Inc. (416) 646-7299
--------------------------------------------------------------------------------
Source: Market Regulation Services; Market Regulation Services - Halts/Resumptions
Existing Home Sales Off 4.1 Pct. in July
Thursday August 24, 5:07 am ET
By Jeannine Aversa, AP Economics Writer
Existing Home Sales Drop 4.1 Percent in July; Inventory of Unsold Homes Hit Record High
WASHINGTON (AP) -- House hunters shied away from buying in July, driving down sales of previously owned homes to a 2 1/2-year low. The inventory of unsold homes climbed to a record high.
The figures released Wednesday provided fresh evidence of how much the once-sizzling housing market has cooled.
Prospective home buyers have turned cautious about making such a big-ticket purchase as mortgage rates have gone up and uncertainty has risen over whether the economy and job creation will keep slowing, analysts said.
Existing-home sales dropped 4.1 percent in July from the previous month to a seasonally adjusted annual rate of 6.33 million units, the National Association of Realtors reported. That was the lowest level since January 2004.
The latest snapshot of housing activity was weaker than analysts anticipated; they were forecasting a sales pace of 6.55 million.
On Wall Street, the housing report rattled investors and pushed stocks lower. The Dow Jones industrials lost 41.94 points to close at 11,297.90.
Although sale prices for homes are no longer bounding ahead, some prospective buyers are still waiting for better deals, just one more factor in the weak showing, economists said.
"Many potential home buyers have been on the sidelines, some kicking the tires but mostly waiting for sellers to compromise on prices and terms," said David Lereah, the association's chief economist.
The median nationwide price of a home sold last month was $230,000, up just 0.9 percent from the same month last year. The median price is the middle point, where half sell for more and half sell for less.
Meanwhile, the inventory of unsold homes in July rose to a record high of 3.86 million. At the current sales pace, it would take 7.3 months to exhaust that overhang. That is the longest period to exhaust the supply of homes since the spring of 1993.
By region, sales tumbled 6.4 percent in the West in July from the previous month. Sales fell 5.9 percent in the Midwest and 5.4 percent in the Northeast. In the South, sales dipped 1.2 percent.
Wednesday's report shows that the bloom is off the rose.
For five years running, home sales had hit record highs as low mortgage rates lured buyers. But the housing sector has lost steam this year as mortgage rates have gone up and would-be buyers have grown cautious amid high energy prices and a slowing economy.
Against that backdrop, the Federal Reserve this month decided to halt a rate-raising campaign that had pushed interest rates steadily higher over the last two-plus years to fend off inflation.
The Fed's goal is to raise rates sufficiently to thwart inflation but not enough to hurt the economy.
One of the things that Federal Reserve Board Chairman Ben Bernanke and his colleagues are watching closely is the housing slowdown. If home prices and sales were to crash, that could spell big trouble for the overall economy. Thus far, Bernanke has said the market's slowdown has been fairly orderly and smooth.
Wednesday's figures made some economists worry about the potential for a sharper slowdown in housing.
Lereah said he still expects a "soft landing" for the housing sector. But he urged the Fed to leave interest rates alone and refrain from bumping them up again -- as some analysts have said is a possibility.
The housing sector's transition from a red-hot market to a cool one has important implications for the overall economy.
Consumers who watched their homes rise rapidly in value over the last several years felt wealthy and more inclined to spend. They also borrowed against their homes -- treating them like ATMs -- to support their spending ways.
But with home values nationwide not going up as much now as the double-digit gains seen in the past several years, consumers have tightened their belts. That has contributed to a slowing in overall economic activity.
"Once upon a time there was a housing market that allowed homeowners to print money. Those days are gone," said Joel Naroff of Naroff Economic Advisors.
Recent reports underscore the housing slowdown's impact.
Luxury home builder Toll Brothers Inc. on Tuesday reported a sharp drop in third-quarter profits. One day earlier Lowe's Cos., the nation's second-largest home-improvement chain, warned that a slowing housing market will hurt its earnings for the rest of the year.
Last week the National Association of Home Builders reported that confidence among builders sank to a 15-year low.
National Association of Realtors: http://www.realtor.org/
CBMX / ACTG - CombiMatrix Updates Influenza Array with New Flu Sequences from the Centers for Disease Control
Thursday August 24, 6:00 am ET
The US Centers for Disease Control and Prevention Has Released Sequences from Influenza Strains Including Those from the Recent Human Deaths in Indonesia
NEWPORT BEACH, Calif.--(BUSINESS WIRE)--Aug. 24, 2006--Acacia Research Corporation announced today that its CombiMatrix group (Nasdaq:CBMX - News; Nasdaq:ACTG - News) is making available an updated version of its Influenza A Array. Incorporated into version 3.0 are the new sequences that have been released by the US Centers for Disease Control and Prevention (CDC), which include the strains from the recent infections and deaths in Indonesia.
For more information about the CDC's release, see the following link: http://hosted.ap.org/dynamic/stories/C/CDC_FLU_GENES?SITE=AP& SECTION=HOME&TEMPLATE=DEFAULT&CTIME=2006-08-23-01-15-16. (Due to its length, this URL may need to be copied/pasted into your Internet browser's address field. Remove the extra space if one exists.)
CombiMatrix's arrays are being used today in various testing programs in different regions of the world to track Eurasian avian influenza H5N1, or bird flu. These tests are utilizing version 2.0 of the Influenza A Array. Subsequent programs will utilize version 3.0 and other updated versions that CombiMatrix will make available as new sequence and mutation information becomes public.
As before, the new Influenza A Microarray can identify all strains of Influenza A, including bird and human varieties. By tracking changes in genetic makeup of the virus, this array can differentiate highly pathogenic from less-lethal flu strains and can identify strains that may be resistant to drug therapy.
"Again we demonstrate the strength of our technology in taking the most up-to-date genetic information and incorporating it into an array that can be used for research and diagnostics," said Dr. Amit Kumar, President and CEO of CombiMatrix. "We applaud the CDC in its effort to make this information public, and we support its efforts as well as that of the WHO in encouraging other labs around the world to do the same."
ABOUT ACACIA RESEARCH CORPORATION
Acacia Research Corporation comprises two operating groups, Acacia Technologies group and CombiMatrix group.
The CombiMatrix group is developing a platform technology to rapidly produce CUSTOMARRAYS(TM), which are semiconductor-based tools for use in identifying and determining the roles of genes, gene mutations and proteins. The CombiMatrix's group's technology has a wide range of potential applications in the areas of genomics, proteomics, biosensors, drug discovery, drug development, diagnostics, combinatorial chemistry, material sciences and nanotechnology.
The Acacia Technologies group develops, acquires, and licenses patented technologies. Acacia controls 46 patent portfolios covering technologies used in a wide variety of industries including audio/video enhancement & synchronization, broadcast data retrieval, computer memory cache coherency, credit card fraud protection, database management, data encryption & product activation, digital media transmission (DMT®), digital video production, dynamic manufacturing modeling, enhanced Internet navigation, hearing aid ECS, image resolution enhancement, interactive data sharing, interactive television, laptop docking station connectivity, microprocessor enhancement, multi-dimensional bar codes, network data storage, resource scheduling, rotational video imaging, spreadsheet automation, user activated Internet advertising and web conferencing & collaboration software.
Acacia Research-Acacia Technologies (Nasdaq:ACTG - News) and Acacia Research-CombiMatrix (Nasdaq:CBMX - News) are both classes of common stock issued by Acacia Research Corporation and are intended to reflect the performance of the respective operating groups and are not issued by the operating groups.
Information about the Acacia Technologies group and the CombiMatrix group is available at www.acaciaresearch.com.
Safe Harbor Statement under the Private Securities Litigation Reform Act of 1995:
This news release contains forward-looking statements within the meaning of the "safe harbor" provisions of the Private Securities Litigation Reform Act of 1995. These statements are based upon our current expectations and speak only as of the date hereof. Our actual results may differ materially and adversely from those expressed in any forward-looking statements as a result of various factors and uncertainties, including the economic slowdown affecting technology companies, our ability to successfully develop products, rapid technological change in our markets, changes in demand for our future products, legislative, regulatory and competitive developments and general economic conditions. Our Annual Report on Form 10-K, recent and forthcoming Quarterly Reports on Form 10-Q, recent Current Reports on Forms 8-K and 8-K/A, and other SEC filings discuss some of the important risk factors that may affect our business, results of operations and financial condition. We undertake no obligation to revise or update publicly any forward-looking statements for any reason.
Contact:
Acacia Research Corporation
Bret L. Undem (Media Relations), 425-493-2293
Fax: 425-493-2010
--------------------------------------------------------------------------------
Source: Acacia Research Corporation
ALVR - NTT West-Okinawa Selects Alvarion's BreezeACCESS(R) VL
Thursday August 24, 6:00 am ET
Japanese Incumbent Beginning Broadband Deployment in Rural and Island Areas of Okinawa
TEL AVIV, Israel--(BUSINESS WIRE)--Aug. 24, 2006--Alvarion Ltd. (NASDAQ:ALVR - News), the world's leading provider of wireless broadband solutions and specialized mobile networks, today announced that NTT West-Okinawa Corporation, a subsidiary of NTT West, has signed a supply agreement for its BreezeACCESS VL system. The Japanese incumbent is beginning a broadband deployment to serve the rural and island areas of Okinawa where wired infrastructure is too difficult and costly to deploy.
"We selected Alvarion's BreezeACCESS VL after an extensive trial period," said Kenichi Honda, president of NTT West-Okinawa. "Given our island topography, we need a robust system that is easy to deploy and offers high quality services in non line-of-sight conditions. We are impressed with both the VL's overall performance and cost effectiveness, and the result is we now see a way to close the digital divide in our region."
BreezeACCESS VL's enhanced features such as OFDM non-line-of-sight (NLOS), extended reach of more than 30 kilometers (19 miles), high capacity, encryption and quality of service (QoS) mechanisms enable carriers, mobile operators, ISPs, enterprises and others can use the VL to provide triple play services to business and residential subscribers in the 5 GHz bands. With its advanced features such as 20 MHz channel spacing and automatic clear channel selection (ACCS) and its built-in spectrum analyzer to monitor the noise on each channel, BreezeACCESS VL enables greater flexibility in frequency planning.
"We are very excited to strengthen our relationship with NTT West-Okinawa, one of the world's largest incumbent carriers, as they deploy broadband services throughout Okinawa," said Tzvika Friedman, president and CEO of Alvarion. "Our BreezeACCESS VL provides broadband with quality of service to thousands of users over large coverage areas and is an excellent choice for island terrain. This deployment is a direct result of our flexibility and investments in optimizing the VL for the local Japanese market."
With a per chassis maximum capacity on the base station of over 300 Mbps in a single 3U shelf, carriers offers subscribers up to 32 Mbps (net FTP). The BreezeACCESS VL is supported by AlvariSTAR(TM), a carrier-class network management system that simplifies network deployment and enables rapid expansion of a service provider's customer base with effective fault management for quick resolution.
About NTT West-Okinawa Corporation
NTT West-Okinawa Corporation is part of NTT West Group Companies, which is part of NTT Group the incumbent operator in Japan. NTT West provides Regional Telecommunication Services in the west area of Japan. Such Telecommunication services include: Telephone services, Integrated Digital services, Leased Line service and so on.
For more information visit NTT West website: www.ntt-west.co.jp/index_e2.html
About Alvarion
With more than 2 million units deployed in 150 countries, Alvarion is the world's leading provider of innovative wireless network solutions enabling personal broadband services to improve lifestyles and productivity with portable and mobile data, VoIP, video and other applications. Providing systems to carriers, ISPs and private network operators, the company also supplies solutions to extend coverage of GSM and CDMA mobile networks to developing countries and other hard to serve areas.
Leading the WiMAX revolution, Alvarion has the most extensive deployments and proven product portfolio in the industry covering the full range of frequency bands with both fixed and mobile solutions. Alvarion's products enable the delivery of business and residential broadband access, corporate VPNs, toll quality telephony, mobile base station feeding, hotspot coverage extension, community interconnection, public safety communications, and mobile voice and data. Alvarion works with several global OEM providers and more than 200 local partners to support its diverse global customer base in solving their last-mile challenges.
As a wireless broadband pioneer, Alvarion has been driving and delivering innovations for more than 10 years from core technology developments to creating and promoting industry standards. Leveraging its key roles in the IEEE and HiperMAN standards committees and experience in deploying OFDM-based systems, the Company's prominent work in the WiMAX Forum(TM) is focused on increasing the widespread adoption of standards-based products in the wireless broadband market and leading the entire industry to mobile WiMAX solutions. For more information, visit Alvarion's World Wide Web site at www.alvarion.com.
This press release contains forward -looking statements within the meaning of the "safe harbor" provisions of the Private Securities Litigation Reform Act of 1995. These statements are based on the current expectations or beliefs of Alvarion's management and are subject to a number of factors and uncertainties that could cause actual results to differ materially from those described in the forward -looking statements. The following factors, among others, could cause actual results to differ materially from those described in the forward-looking statements: inability to further identify, develop and achieve success for new products, services and technologies; increased competition and its effect on pricing, spending, third-party relationships and revenues; as well as the in ability to establish and maintain relationships with commerce, advertising, marketing, and technology providers and other risks detailed from time to time in filings with the Securities and Exchange Commission.
Information set forth in this press release pertaining to third parties has not been independently verified by Alvarion and is based solely on publicly available information or on information provided to Alvarion by such third parties for inclusion in this press release. The web sites appearing in this press release are not and will not be included or incorporated by reference in any filing made by Alvarion with the Securities and Exchange Commission, which this press release will be a part of.
You may request Alvarion's future press releases or a complete Investor Kit by contacting Carmen Deville, Investor Relations: carmen.deville@alvarion.com or +1.650.314.2653.
Contact:
Alvarion Ltd.
Investors:
Dafna Gruber, +972-3-645-6252 / 650-314-2652
dafna.gruber@alvarion.com
or
Carmen Deville, 650-314-2653
carmen.deville@alvarion.com
or
Press:
In the U.S.
Heather Mills, 1-972-341-2512
hmills@golinharris.com
or
In the U.K.
Bridget Fishleigh, +44-1273-305-936
bridget@nomadcomms.com
--------------------------------------------------------------------------------
Source: Alvarion Ltd.
RAD - Rite Aid will grow to Approximately 5,000 Drugstores as the Jean Coutu Group Agrees to Merge all Brooks and Eckerd Stores into Rite Aid
Thursday August 24, 6:30 am ET
In a Transaction Valued at $3.4 Billion
CAMP HILL, PENNSYLVANIA and LONGUEUIL, QUEBEC--(MARKET WIRE)--Aug 24, 2006 -- Rite Aid Corporation (NYSE:RAD - News)(NYSE:RAD - News) and The Jean Coutu Group (PJC) Inc. (TSX:PJC-A.TO - News):
- The Jean Coutu Group Will Receive $1.45 Billion in Cash and a 32.0% Common Equity - Interest In Rite Aid, Making It the Leading Rite Aid Shareholder; Rite Aid Also Intends - To Assume $850 Million of Jean Coutu Group Long-Term Debt
- Transaction Accelerates Rite Aid's Growth Strategy, Giving Company Scale Comparable - To Its Major Competitors; Expected to be Accretive to Rite Aid Earnings Twelve Months After Closing
- Transforms The Jean Coutu Group's U.S. Regional Drugstore Investment Into Significant Interest in Major National U.S. Chain
- Rite Aid President and CEO Mary Sammons Will Continue to Lead Company and - Also Become Rite Aid Chairman; Michel Coutu, President of The Jean Coutu Group's U.S. Operations, Will Become Rite Aid Co-Chairman
- All Acquired Stores Will Be Re-branded Rite Aid
Rite Aid Corporation (NYSE:RAD - News)(NYSE:RAD - News) and The Jean Coutu Group (PJC) Inc. (TSX:PJC-A.TO - News) announced today that they have entered into a definitive agreement on a transaction in which its US subsidiary, The Jean Coutu Group (PJC) USA Inc., will be merged into Rite Aid, strengthening Rite Aid's position as the third largest national drugstore chain in the United States and creating the largest drugstore chain on the East Coast. The Jean Coutu Group (PJC) USA includes 1,858 drugstores (337 Brooks stores and 1,521 Eckerd stores) and six distribution centers, all located primarily on the East Coast and in the Mid-Atlantic states. All of the stores will be re-branded Rite Aid and Rite Aid headquarters will remain in Camp Hill, PA.
Under the transaction, The Jean Coutu Group will receive $1.45 billion in cash, subject to customary working capital adjustments, and 250 million shares of Rite Aid common stock giving it a 32.0% common equity interest and 30.2% of the voting power in the expanded Rite Aid. Rite Aid also intends to assume $850 million of The Jean Coutu Group's long-term debt. Based on Rite Aid's prior one-month average closing share price, the transaction would be valued at approximately $3.4 billion. The Jean Coutu Group will continue to independently act as franchisor and distributor for its Canadian network currently consisting of 327 franchised drugstores located in three provinces.
Upon completion of the transaction, which has been approved by the Boards of Directors of both companies, there will be approximately 5,000 Rite Aid stores in 31 states and the District of Columbia, with coverage on both the East and West coasts. The stores Rite Aid will acquire are located in 18 states, with Rite Aid currently operating in 14 of the states and adding Massachusetts, Rhode Island, South Carolina and North Carolina to its national footprint. The combined fiscal 2006 revenues of Rite Aid and The Jean Coutu Group (PJC) USA were approximately $26.8 billion.
Mary Sammons will continue to lead Rite Aid as President and CEO while also becoming Chairman of the Rite Aid Board of Directors. Michel Coutu, currently President of The Jean Coutu Group's U.S. operations, will become Co-Chairman of Rite Aid's Board and a member of the Board's Executive Committee. The Jean Coutu Group will name three other independent members to a 14-person Rite Aid Board, including Francois J. Coutu, Vice Chairman of The Jean Coutu Group, Andre Belzile, Senior Vice President of Finance and Corporate Affairs of The Jean Coutu Group, and Dennis Wood, one of the independent members of The Jean Coutu Group's Board of Directors. Robert G. Miller, the current Rite Aid Chairman, will continue to serve as a Director. Also, Pierre Legault, The Jean Coutu Group's Executive Vice President who was recently appointed to run its U.S. operations, will become Rite Aid Senior Executive Vice President, Chief Administrative Officer, while Rite Aid's current senior management team remains in place. As CAO, Mr. Legault will be responsible for finance, information technology and real estate and will be a member of the integration leadership team along with Ms. Sammons, Jim Mastrian, Rite Aid Chief Operating Officer, and Chris Hall, Rite Aid Senior Vice President of Strategic Business Development.
Rite Aid expects the transaction will enable it to achieve significant cost efficiencies in the areas of merchandising, purchasing, advertising and distribution as well as administrative expense. Net synergies are estimated to be $150 million after the first twelve months following the close, with some net synergies experienced during the first twelve months. The company said it expects the transaction to be accretive 12 months after the close by $.09 to $.15 per diluted share. The company said it expects the transaction to be dilutive by $.03 to $.07 per diluted share for the first twelve months because of integration and non-recurring expenses associated with the transaction. The estimate of dilution for the first twelve months does not include a gain or loss on any regulatory-required store dispositions.
Unique Opportunity to Accelerate Rite Aid Growth Strategy
Ms. Sammons said: "We're very excited about this unique opportunity that dramatically accelerates our growth strategy, particularly in areas where we've been focusing our new store development. The Brooks and Eckerd stores are in good locations with dedicated associates committed to serving their customers and their communities. Adding these stores to our company gives Rite Aid scale comparable to our major drugstore competitors, and we believe this enables us to compete more effectively in a highly competitive business. We also look forward to bringing the Rite Aid shopping experience to four new states while at the same time, we continue our organic growth program with our very successful "Customer World" store design.
Sammons continued: "Successfully integrating these stores requires a strong infrastructure like the one we have built at Rite Aid, with information systems and a supply chain already capable of supporting a significant increase in the number of stores. We believe the stores will also benefit from our proven front-end merchandising programs, innovative advertising and promotion programs, successful pharmacy marketing initiatives, solid supplier relationships, state-of-the-art technology and strong field structure. With 70 percent of the acquired stores located in states where we already operate, we expect to leverage our systems, programs, best practices and executive management talent to improve profitability by achieving substantial cost savings and growing sales. We'll also capitalize on our leadership team's expertise in retail mergers and turnarounds and plan to make a significant financial investment to improve the acquired stores. We look forward to working with Brooks and Eckerd associates to effect a smooth transition and create a distinctive health and wellness focused shopping experience second to none."
Optimizes The Jean Coutu Group's U.S. Investment
Jean Coutu, Chairman, President and CEO of The Jean Coutu Group, said, "We see this transaction as a unique strategic opportunity to optimize our U.S. presence by transforming our investment in a regional drugstore chain into the leading ownership position in a major national chain with the scale to better compete in the growing U.S. drugstore industry. The Jean Coutu Group and its four designated Directors, who will be members of Rite Aid's various Board committees, are proud to be associated with Rite Aid's management. We are confident that the team has the skills and experience to leverage its capabilities across a larger network. At the same time, this transformational event allows us to deleverage our balance sheet, maintain focus on our leading Canadian franchise and should generate significant value for our shareholders."
Rite Aid recently increased its sales guidance for fiscal 2007, citing positive pharmacy same store sales trends and continuing solid front end same-store sales gains. The company also remains on target with its organic new store development program with plans to open 800 to 1,000 new stores over the next five years.
Rite Aid expects to finance the transaction with a combination of existing excess cash on hand and through a combination of bank borrowings, the issuance of debt securities, the expected assumption of previously issued Jean Coutu Group 8.5% Senior Subordinated Notes in the amount of $850 million, subject to satisfaction of certain conditions, and the issuance of 250 million shares of common stock. In the event the $850 million Senior Subordinated Notes are not assumed by Rite Aid, the cash paid would increase to $2.3 billion and Rite Aid would issue additional debt securities to fund the increased cash consideration. A financing commitment has been obtained from Citigroup North America, Inc. and Citigroup Global Markets Inc.
Pro forma financial impact of the transaction on The Jean Coutu Group
The investment by The Jean Coutu Group in Rite Aid will be accounted for using the equity method in future periods. US operations will not be presented as discontinued operations considering the continuing involvement by the company in the business. The estimated proceeds on disposal of $3.4 billion are subject to fluctuation due to changes in the US dollar per Canadian dollar exchange rate and the Rite Aid share price until the transaction closes. Based on Rite Aid's prior one-month average closing share price of $4.41 and an average exchange rate of 0.8885 US dollars per Canadian dollar, The Jean Coutu Group would have recorded an after-tax loss of approximately $140 million from the transaction.
Closing of the transaction is subject to review under the Hart-Scott-Rodino Act, Rite Aid stockholder approval and other customary closing conditions. The closing date is dependent on these activities but could be as early as Rite Aid's fiscal 2007 fourth quarter, which begins December 3, 2006 and ends March 3, 2007, and The Jean Coutu Group's fiscal 2007 third quarter, which begins on November 26, 2006 and ends February 24, 2007.
The Brooks stores Rite Aid will acquire are located in Maine, Vermont, New Hampshire, Massachusetts, Rhode Island and Connecticut. The Eckerd stores Rite Aid will acquire are located in New York, Pennsylvania, New Jersey, Maryland, Delaware, Virginia, West Virginia, Tennessee, North Carolina, South Carolina, Georgia and Ohio. The distribution centers Rite Aid will acquire are located in Atlanta, GA; Charlotte, NC; Philadelphia, PA; Dayville, CT; Syracuse, NY and Bohemia, NY. The transaction also includes The Jean Coutu Group (PJC) USA's corporate headquarters in Warwick, Rhode Island.
Financial advisors for Rite Aid are Citigroup Corporate and Investment Banking inc. and Rothschild Inc.; exclusive financial advisor for The Jean Coutu Group is J.P. Morgan Securities, Inc.
Joint Conference Call Scheduled for 9:30 a.m. Eastern Time Today
Rite Aid and The Jean Coutu Group will host a joint conference call for analysts and the investment community at 9:30 a.m. Eastern Time today, August 24, with remarks on today's announcement by the management teams of both companies. The conference call number is 1-877-654-4425 from within the U.S. and Canada or 1-706-679-0005 from outside the U.S. and Canada. We suggest you dial in 10 to 15 minutes before the call. The call will be simulcast via the internet and can be accessed through the websites at www.riteaid.com and www.jeancoutu.com in the conference call section of investor information as well as on www.StreetEvents.com and www.ccnmatthews.com.
A telephone replay will be available for 48 hours beginning at 1 p.m. Eastern Time today and ending at 1 p.m. Eastern Time on Saturday, August 26. To access playback of the call, telephone 1-800-642-1687 from within the U.S. and Canada or 1-706-645-9291 from outside the U.S. and Canada and enter the seven-digit reservation number 5113848.
A playback of the call will also be available on the internet at www.riteaid.com, www.jeancoutu.com, www.StreetEvents.com and www.ccnmatthews.com starting at 2 p.m. Eastern Time today. The playback will be available on these sites until 5 p.m. Eastern Time September 25, 2006.
About Rite Aid
Rite Aid Corporation is the third largest national drugstore chain in the U.S. in total revenues and store count with annual revenues of $17.3 billion, 3,319 corporate-owned stores in 27 states and the District of Columbia and 70,500 associates. Information about Rite Aid, including corporate background and press releases, is available through the company's website at www.riteaid.com.
This press release may contain forward-looking statements, which are subject to certain risks and uncertainties that could cause actual results to differ materially from those expressed or implied in the forward-looking statements. Factors that could cause actual results to differ materially from those expressed or implied in such forward-looking statements include our high level of indebtedness, our ability to make interest and principal payments on our debt and satisfy the other covenants contained in our senior secured credit facility and other debt agreements, our ability to improve the operating performance of our existing stores in accordance with our long term strategy, our ability to hire and retain pharmacists and other store personnel, the efforts of private and public third-party payors to reduce prescription drug reimbursements and encourage mail order, competitive pricing pressures, continued consolidation of the drugstore industry, changes in state or federal legislation or regulations, the outcome of lawsuits and governmental investigations, general economic conditions and inflation, interest rate movements, access to capital, the ability of Rite Aid to consummate the transaction with the Jean Coutu Group and realize the benefits of such transaction and our ability to assume the senior subordinated notes. Consequently, all of the forward-looking statements made in this press release are qualified by these and other factors, risks and uncertainties. Readers are also directed to consider other risks and uncertainties discussed in documents filed by the Company with the Securities and Exchange Commission. Forward-looking statements can be identified through the use of words such as "may", "will", "intend", "plan", "project", "expect", "anticipate", "could", "should", "would", "believe", "estimate", "contemplate", and "possible".
See the 8-K furnished to the Securities and Exchange Commission on June 22, 2006 for definition, purpose and reconciliation of non-GAAP financial measures referred to herein to most comparable GAAP financial measures.
About The Jean Coutu Group
The Jean Coutu Group (PJC) Inc. is the fourth largest drugstore chain in North America and the second largest in both the Eastern United States and Canada. The company and its combined network of 2,185 corporate and franchised drugstores (under the banners of Brooks and Eckerd Pharmacy, PJC Jean Coutu, PJC Clinique and PJC Sante Beaute) employ more than 61,000 people.
The Jean Coutu Group's U.S. operations employ 46,000 people and comprise 1,858 corporate owned stores located in 18 states of the Northeastern, mid-Atlantic and Southeastern United States. The Jean Coutu Group's Canadian operations and franchised drugstores in its network employ over 15,000 people and comprise 327 PJC Jean Coutu franchised stores in Quebec, New Brunswick and Ontario. Information about The Jean Coutu Group, including corporate background and press releases, is available through the company's website at www.jeancoutu.com.
Certain statements contained in this press release may constitute "forward-looking statements" within the meaning of the US Private Securities Litigation Reform Act of 1995. The words "looking forward," "looking ahead," "believe(s)," "should," "may," "expect(s)," "anticipate(s)," "likely," "opportunity," and similar expressions, among others, identify forward-looking statements. Such statements are not guarantees of the future performance of The Jean Coutu Group (PJC) Inc. or its segments, and involve known and unknown risks and uncertainties that may cause the outlook, the actual results or performance of the company or of its reportable segments to be materially different from any future results or performance expressed or implied by such statements depending on, among others, such factors as changes in the regulatory environment as it relates to the sale of prescription drugs, competition, exposure to interest rate fluctuations, foreign currency risks, certain property and casualty risks, the ability to attract and retain pharmacists, risks in connection with third party service providers, seasonality risks, changes in federal, provincial and state laws, rules and regulations relating to the company's business and environmental matters, changes in tax regulations and accounting pronouncements, the success of the company's business model, supplier and brand reputations, and the accuracy of management's assumptions. This list is not exhaustive of the factors that may affect any of the company's forward-looking statements. For further information, readers are referred to the section on Risks and uncertainties contained in the company's MD&A as well as in other filings. The company disclaims any intention or obligation to update or revise any forward-looking information contained in its communications, whether as a result of new information, future events or otherwise.
This press release also contains certain non-GAAP financial measures. Such information is reconciled to the most directly comparable financial measures, as set forth in the company's management Discussion and Analysis, included in its most recent Annual Report.
ADDITIONAL INFORMATION AND WHERE TO FIND IT
Rite Aid intends to file with the Securities and Exchange Commission a proxy statement in connection with the proposed transaction. The proxy statement will be mailed to the stockholders of Rite Aid. STOCKHOLDERS OF RITE AID ARE ADVISED TO READ THE PROXY STATEMENT WHEN IT BECOMES AVAILABLE, BECAUSE IT WILL CONTAIN IMPORTANT INFORMATION. Such proxy statement (when available) and other relevant documents may also be obtained, free of charge, on the Securities and Exchange Commission's website (http://www.sec.gov) or by contacting our Secretary, Rite Aid Corporation, 30 Hunter Lane, Camp Hill, Pennsylvania 17011.
PARTICIPANTS IN THE SOLICITATION
Rite Aid and certain persons may be deemed to be participants in the solicitation of proxies relating to the proposed transaction. The participants in such solicitation may include Rite Aid's executive officers and directors. Further information regarding persons who may be deemed participants will be available in Rite Aid's proxy statement to be filed with the Securities and Exchange Commission in connection with the transaction.
Contact:
Contacts:
INVESTORS
Rite Aid Corporation
Kevin Twomey
(717) 731-6540
investor@riteaid.com
The Jean Coutu Group (PJC) Inc.
Michael Murray
(450) 646-9611 ext. 1068
IR@jeancoutu.com
MEDIA
Rite Aid Corporation
Karen Rugen
(717) 730-7766
The Jean Coutu Group (PJC) Inc.
Helen Bisson
(450) 646-9611 ext. 1165
--------------------------------------------------------------------------------
Source: The Jean Coutu Group (PJC) Inc. and Rite Aid Corporation
ADNL - Adrenaline Nation Entertainment, Inc. Releases Business Update to Shareholders
Wednesday August 23, 4:56 pm ET
CEO Reports on Adrenaline Nation Entertainment's Authorized and Outstanding Shares as of August 23, 2006
CLEARWATER, Fla., Aug. 23, 2006 (PRIMEZONE) -- Adrenaline Nation Entertainment, Inc. (Other OTC:ADNL.PK - News), which produces Adrenaline Nation TV, the leading channel for the hottest cutting edge independent music TV, innovative independent and short films and adrenaline sports for the highly coveted 18-49 demographic, released the following business update to shareholders.
Dear Fellow Shareholders,
Adrenaline Nation Entertainment, Inc. has achieved numerous major milestones since it began trading as a public company in June of 2005. As a result of these milestones, we have experienced tremendous trading volume in our stock. Therefore I want to ensure that our valued shareholders have the correct number of shares Authorized and Outstanding. As of August 23, 2006 the number of shares Authorized is 950,000,000 and the number of shares Outstanding is 603,539,087. This information can additionally be found on the Pink Sheets web site at http://www.pinksheets.com.
We as always are working hard to build our company and thank our shareholders for their support and belief in our company.
We are passionate here at ADNL about our business model and the results we believe we can derive from it. We are music, entertainment and television market enthusiasts with proven track records, and we are genuinely excited about our business prospects. We are all committed to working hard to building a leading music, entertainment and adrenaline sports broadband, cable and HD television network that is widely recognized by our viewers and advertisers as well as the financial marketplace. We have made substantial progress in positioning ourselves for the opportunities that are before us. On behalf of management and everyone working here at ADNL, I sincerely thank all of our shareholders for their support.
Best Regards,
Keith Dressel
CEO & Chairman
Adrenaline Nation Entertainment, Inc.
Forward-Looking Statements
This document contains forward-looking statements and information as that term is defined in the Private Securities Litigation Reform Act of 1995, and, therefore, is subject to certain risks and uncertainties. There can be no assurance that the actual results, business conditions, business developments, losses and contingencies and local and foreign factors will not differ materially from those suggested in the forward-looking statements as a result of various factors, including market conditions, competition, advances in technology and other factors.
HTML: http://newsroom.eworldwire.com/releases/15343
PDF: http://newsroom.eworldwire.com/pdf/15343.pdf
ONLINE NEWSROOM: http://newsroom.eworldwire.com/308624.htm
NEWSROOM RSS FEED: http://newsroom.eworldwire.com/xml/newsrooms/308624.xml
LOGO: http://newsroom.eworldwire.com/308624.htm
Contact:
CNC Associates
Cathy Clarke
617-527-2089
cathy@cncapr.com
--------------------------------------------------------------------------------
Source: Adrenaline Nation Entertainment, Inc.
CMXG - Infosmart Completes $7.65 Million Equity Financing and Merges Into Public Shell
Wednesday August 23, 6:41 pm ET
Capital Infusion Positions World's 10th Largest DVD Manufacturer to Become Largest DVDR Manufacturer in Brazil
HONG KONG--(MARKET WIRE)--Aug 23, 2006 -- Infosmart Group Limited ("Infosmart"), a Hong Kong-based recordable digital versatile disk (or DVDR) manufacturing company, announced today that on August 16, 2006 it completed a reverse merger with Cyber Merchants Exchange, Inc. ("Cyber Merchants") (OTC BB:CMXG.OB - News), a publicly traded shell company. Contemporaneous with the closing of the reverse merger, Cyber Merchants completed a private placement to certain institutional investors and other high net worth individuals for gross proceeds of $7.65 million. Keating Securities, LLC ("Keating Securities") and Axiom Capital Management, Inc. acted as co-placement agents to Infosmart in the private placement; Keating Securities acted as sole financial advisor to Cyber Merchants in the reverse merger.
At the closing of the reverse merger, Cyber Merchants issued to Infosmart's stockholders 1,000,000 shares of Cyber Merchants' Series A Convertible Preferred Stock in exchange for all of Infosmart's outstanding common stock. Each share of Cyber Merchants' Series A Convertible Preferred Stock will be convertible into approximately 116.72 shares of Cyber Merchants' common stock. The Series A Convertible Preferred Stock does not pay a dividend unless the Company pays cash dividends or dividends in other property to holders of the outstanding shares of Cyber's common stock in which event, each outstanding share of the Series A Convertible Preferred Stock will be entitled to receive dividends of cash or property in an amount or value equal to the conversion rate (initially set at 116.721360 but subject to adjustment) multiplied by the amount paid in respect of one share of common stock. Upon Cyber Merchants' filing of an amendment to its Articles of Incorporation to increase the authorized number of shares of common stock from 40,000,000 to 300,000,000, all of the outstanding Series A Convertible Preferred Stock will immediately and automatically convert into a total of 116,721,360 shares of Cyber Merchants common stock.
As part of the private placement, Cyber Merchants also issued a total of 1,092,857.1429 shares of Cyber Merchants' Series B Convertible Preferred Stock with a stated value of $7.00 per share and warrants to purchase 100% of the amount of shares of common stock into which the Series B Preferred Stock may be converted. The Series B Preferred Stock pays an 8% annual dividend and is convertible into shares of Cyber Merchants' common stock at the election of holders at a conversion price equal to $0.261 per share, subject to standard conversion price adjustments. In total, the Series B Preferred Stock is convertible into 29,310,345 shares of Cyber Merchants common stock. The attached warrants are exercisable into an additional 29,310,345 shares of Cyber Merchants common stock.
Assuming the full conversion of the Series A and Series B Preferred Stock, the as converted basic number of shares of common stock outstanding is 159,000,745. On a fully diluted and as converted basis, Cyber Merchants has 191,242,125 shares of common stock outstanding.
"We are extremely pleased with this transaction, as it allows us to extend our reach in Brazil -- one of the world's largest developing economies. With this infusion of additional capital, we believe that Infosmart is positioned to become the largest DVDR manufacturer in Brazil in 2007 and will be able to capture a large share of this lucrative market before other competitors enter," stated Infosmart CEO Andy Kwok. Mr. Kwok further stated that, "Keating Investments' turnkey going public program has provided Infosmart with the capital to accomplish our objectives in Brazil, and their market-making and after market support services will result over time in an actively traded and fully valued stock, benefiting all Infosmart stockholders."
About Infosmart Group Limited
Infosmart Group Limited, a fast-growing and profitable writable DVD (DVDR) manufacturer, operates a state of the art DVDR production facility in Hong Kong and is preparing to manufacture new writable High Density (HD-DVDR) media. In addition, Infosmart will soon become the largest manufacturer of DVDR discs in Brazil. Disc media will be the storage media of choice for years to come, whether as HD-DVDR for mature markets or traditional DVDR for developing markets. No other storage media available rivals its combination of high capacity, low cost and exceptional portability.
About the Keating Companies
Founded in 1997, Keating Investments, LLC (www.keatinginvestments.com) is the parent company of Keating Securities, LLC, a Denver-based broker-dealer and NASD member that provides a turnkey solution to private companies going public via reverse merger. After Market Support, LLC is a wholly owned subsidiary of Keating Investments, LLC that provides investor relations services to public companies that have gone public via reverse merger or other alternatives to an IPO.
FORWARD-LOOKING STATEMENTS
The information contained herein includes forward-looking statements. These statements relate to future events or to our future financial performance, and involve known and unknown risks, uncertainties and other factors that may cause our actual results, levels of activity, performance, or achievements to be materially different from any future results, levels of activity, performance or achievements expressed or implied by these forward-looking statements. You should not place undue reliance on forward-looking statements since they involve known and unknown risks, uncertainties and other factors which are, in some cases, beyond our control and which could, and likely will, materially affect actual results, levels of activity, performance or achievements. Any forward-looking statement reflects our current views with respect to future events and is subject to these and other risks, uncertainties and assumptions relating to our operations, results of operations, growth strategy and liquidity. We assume no obligation to publicly update or revise these forward-looking statements for any reason, or to update the reasons actual results could differ materially from those anticipated in these forward-looking statements, even if new information becomes available in the future. The safe harbor for forward-looking statements contained in the Securities Litigation Reform Act of 1995 protects companies from liability for their forward-looking statements if they comply with the requirements of the Act.
Contact:
CONTACT:
After Market Support, LLC
Justin Davis
Phone: (720) 489-4913
jd@keatingAMS.com
--------------------------------------------------------------------------------
Source: Infosmart Group Limited
CMXG - Infosmart Completes $7.65 Million Equity Financing and Merges Into Public Shell
Wednesday August 23, 6:41 pm ET
Capital Infusion Positions World's 10th Largest DVD Manufacturer to Become Largest DVDR Manufacturer in Brazil
HONG KONG--(MARKET WIRE)--Aug 23, 2006 -- Infosmart Group Limited ("Infosmart"), a Hong Kong-based recordable digital versatile disk (or DVDR) manufacturing company, announced today that on August 16, 2006 it completed a reverse merger with Cyber Merchants Exchange, Inc. ("Cyber Merchants") (OTC BB:CMXG.OB - News), a publicly traded shell company. Contemporaneous with the closing of the reverse merger, Cyber Merchants completed a private placement to certain institutional investors and other high net worth individuals for gross proceeds of $7.65 million. Keating Securities, LLC ("Keating Securities") and Axiom Capital Management, Inc. acted as co-placement agents to Infosmart in the private placement; Keating Securities acted as sole financial advisor to Cyber Merchants in the reverse merger.
At the closing of the reverse merger, Cyber Merchants issued to Infosmart's stockholders 1,000,000 shares of Cyber Merchants' Series A Convertible Preferred Stock in exchange for all of Infosmart's outstanding common stock. Each share of Cyber Merchants' Series A Convertible Preferred Stock will be convertible into approximately 116.72 shares of Cyber Merchants' common stock. The Series A Convertible Preferred Stock does not pay a dividend unless the Company pays cash dividends or dividends in other property to holders of the outstanding shares of Cyber's common stock in which event, each outstanding share of the Series A Convertible Preferred Stock will be entitled to receive dividends of cash or property in an amount or value equal to the conversion rate (initially set at 116.721360 but subject to adjustment) multiplied by the amount paid in respect of one share of common stock. Upon Cyber Merchants' filing of an amendment to its Articles of Incorporation to increase the authorized number of shares of common stock from 40,000,000 to 300,000,000, all of the outstanding Series A Convertible Preferred Stock will immediately and automatically convert into a total of 116,721,360 shares of Cyber Merchants common stock.
As part of the private placement, Cyber Merchants also issued a total of 1,092,857.1429 shares of Cyber Merchants' Series B Convertible Preferred Stock with a stated value of $7.00 per share and warrants to purchase 100% of the amount of shares of common stock into which the Series B Preferred Stock may be converted. The Series B Preferred Stock pays an 8% annual dividend and is convertible into shares of Cyber Merchants' common stock at the election of holders at a conversion price equal to $0.261 per share, subject to standard conversion price adjustments. In total, the Series B Preferred Stock is convertible into 29,310,345 shares of Cyber Merchants common stock. The attached warrants are exercisable into an additional 29,310,345 shares of Cyber Merchants common stock.
Assuming the full conversion of the Series A and Series B Preferred Stock, the as converted basic number of shares of common stock outstanding is 159,000,745. On a fully diluted and as converted basis, Cyber Merchants has 191,242,125 shares of common stock outstanding.
"We are extremely pleased with this transaction, as it allows us to extend our reach in Brazil -- one of the world's largest developing economies. With this infusion of additional capital, we believe that Infosmart is positioned to become the largest DVDR manufacturer in Brazil in 2007 and will be able to capture a large share of this lucrative market before other competitors enter," stated Infosmart CEO Andy Kwok. Mr. Kwok further stated that, "Keating Investments' turnkey going public program has provided Infosmart with the capital to accomplish our objectives in Brazil, and their market-making and after market support services will result over time in an actively traded and fully valued stock, benefiting all Infosmart stockholders."
About Infosmart Group Limited
Infosmart Group Limited, a fast-growing and profitable writable DVD (DVDR) manufacturer, operates a state of the art DVDR production facility in Hong Kong and is preparing to manufacture new writable High Density (HD-DVDR) media. In addition, Infosmart will soon become the largest manufacturer of DVDR discs in Brazil. Disc media will be the storage media of choice for years to come, whether as HD-DVDR for mature markets or traditional DVDR for developing markets. No other storage media available rivals its combination of high capacity, low cost and exceptional portability.
About the Keating Companies
Founded in 1997, Keating Investments, LLC (www.keatinginvestments.com) is the parent company of Keating Securities, LLC, a Denver-based broker-dealer and NASD member that provides a turnkey solution to private companies going public via reverse merger. After Market Support, LLC is a wholly owned subsidiary of Keating Investments, LLC that provides investor relations services to public companies that have gone public via reverse merger or other alternatives to an IPO.
FORWARD-LOOKING STATEMENTS
The information contained herein includes forward-looking statements. These statements relate to future events or to our future financial performance, and involve known and unknown risks, uncertainties and other factors that may cause our actual results, levels of activity, performance, or achievements to be materially different from any future results, levels of activity, performance or achievements expressed or implied by these forward-looking statements. You should not place undue reliance on forward-looking statements since they involve known and unknown risks, uncertainties and other factors which are, in some cases, beyond our control and which could, and likely will, materially affect actual results, levels of activity, performance or achievements. Any forward-looking statement reflects our current views with respect to future events and is subject to these and other risks, uncertainties and assumptions relating to our operations, results of operations, growth strategy and liquidity. We assume no obligation to publicly update or revise these forward-looking statements for any reason, or to update the reasons actual results could differ materially from those anticipated in these forward-looking statements, even if new information becomes available in the future. The safe harbor for forward-looking statements contained in the Securities Litigation Reform Act of 1995 protects companies from liability for their forward-looking statements if they comply with the requirements of the Act.
Contact:
CONTACT:
After Market Support, LLC
Justin Davis
Phone: (720) 489-4913
jd@keatingAMS.com
--------------------------------------------------------------------------------
Source: Infosmart Group Limited
GILT - Gilat Provides Multi-Service Satellite Broadband Network With GSM Backhauling Solution to Nicaragua's Largest Telecom Operator
Thursday August 24, 4:50 am ET
New SkyEdge System Brings Latest Mobile Voice, Data and Internet Services to Customers Throughout Nicaragua and Latin America
PETAH TIKVA, Israel--(BUSINESS WIRE)--Aug. 24, 2006--Gilat Satellite Networks Ltd. (Nasdaq:GILT - News), today announced that it has been selected by Empresa Nicaraguense de Telecomunicaciones (Enitel) to provide a SkyEdge broadband satellite hub station and VSAT terminals.
Enitel will be able to use the new SkyEdge system to provide Nicaraguan and Latin American customers with a bundle of services, including Internet access, rural telephony, GSM trunking, fax and prepaid telephony.
SkyAbis is an integral part of the SkyEdge multi-service platform and uses dynamic bandwidth allocation with high space-segment efficiency for GSM backhaul. SkyAbis enables telecom operators to deploy a hybrid network that extends the reach of their terrestrial and cellular infrastructure to remote communities and provide voice and data services where voice coverage was previously unavailable. This unified system presents a low total cost of ownership solution and expands telecom operators' offerings by providing satellite backhaul services to mobile operators.
Enitel is Nicaragua's largest telecommunications operator. Since 2001, Enitel has deployed Gilat VSAT equipment at hundreds of sites to serve residential and corporate customers.
Erez Antebi, CEO for Gilat Network Systems (GNS) a business unit of Gilat Satellite Networks said, "This agreement demonstrates Enitel's confidence in Gilat and SkyEdge's ability to support the very latest broadband voice and data applications for a large number of users, regardless of their geographic location. As we continue our successful relationship with Enitel, we look forward to helping them maintain their strong reputation for service and selection."
Gilat's SkyEdge is a satellite communications platform that delivers high-end voice, data and video services over a single, powerful system. It represents Gilat's deep knowledge base and field-proven product offering, acquired through nearly two decades of experience. SkyEdge's flexible architecture and efficient space segment utilization make it an ideal platform for operators and service providers.
About Enitel
Enitel is Nicaragua's largest telecommunications operator and has a 100% digital network with approximately 350,000 fixed telephony lines in operation. Enitel is capable of providing high-speed data and Internet services to both consumers and businesses. Enitel also provides mobile telephony services (with GSM technology) covering the national territory and serving more than one million users. Enitel is constantly evaluating and adopting technologies that will enable it to offer multiple communications services with single access.
About Gilat Satellite Networks Ltd.
Gilat Satellite Networks Ltd. (Nasdaq:GILT - News) is a leading provider of products and services for satellite-based communications networks. The Company operates under three business units: (i) Gilat Network Systems ("GNS"), which is a provider of network systems and associated professional services to service providers and operators worldwide; (ii) Spacenet Inc., which provides managed services in North America for businesses and governments through its Connexstar service brand and for consumers through its StarBand service brand; (iii) Spacenet Rural Communications, which offers rural telephony and Internet access solutions to remote areas primarily in Latin America.
Gilat was founded in 1987 and has shipped over 600,000 Very Small Aperture Terminals (VSATs) to more than 85 countries across six continents. Gilat's headquarters is located in Petah Tikva, Israel. The Company has 14 local offices and three service facilities worldwide. Gilat markets the SkyEdge (TM) Product Family which includes the SkyEdge(TM) Pro, SkyEdge(TM) IP, SkyEdge(TM) Call, SkyEdge(TM) DVB-RCS and SkyEdge(TM) Gateway. In addition, the Company markets numerous other legacy products.
Certain statements made herein that are not historical are forward-looking within the meaning of the Private Securities Litigation Reform Act of 1995. The words "estimate", "project", "intend", "expect", "believe" and similar expressions are intended to identify forward-looking statements. These forward-looking statements involve known and unknown risks and uncertainties. Many factors could cause the actual results, performance or achievements of Gilat to be materially different from any future results, performance or achievements that may be expressed or implied by such forward-looking statements, including, among others, changes in general economic and business conditions, inability to maintain market acceptance to Gilat's products, inability to timely develop and introduce new technologies, products and applications, rapid changes in the market for Gilat's products, loss of market share and pressure on prices resulting from competition, introduction of competing products by other companies, inability to manage growth and expansion, loss of key OEM partners, inability to attract and retain qualified personnel, inability to protect the Company's proprietary technology and risks associated with Gilat's international operations and its location in Israel. For additional information regarding these and other risks and uncertainties associated with Gilat's business, reference is made to Gilat's reports filed from time to time with the Securities and Exchange Commission.
Contact:
Gilat Media Contact
Director of Corporate Marketing
Shira Gafni, + 972-3-925-2406
shirag@gilat.com
--------------------------------------------------------------------------------
Source: Gilat Satellite Networks, Ltd.
RAD - Rite Aid Said Near Eckerd, Brooks Deal
Thursday August 24, 5:06 am ET
Rite Aid Reportedly Near Multibillion Dollar Deal to Acquire Eckerd, Brooks Chains
NEW YORK (AP) -- Rite Aid Corp. is near a deal to buy the Eckerd and Brooks drugstore chains from Canada's Jean Coutu Group Inc. for more than $2.5 billion in cash and stock, according to newspaper reports.
Under terms being discussed, Rite Aid would pay about $3.4 billion, including $1.5 billion in cash, The Wall Street Journal reported on its Web site Wednesday night, citing two people familiar with the matter.
The New York Times reported the deal's value as $2.55 billion in cash and stock, citing people involved in the deal. Rite Aid, based in Camp Hill, Pa., also would assume about $850 million in debt, the Times reported. The boards of both companies have approved the transaction, which was to be announced on Thursday, the Times report said.
Jean Coutu Group would own about 30 percent of Rite Aid after the deal -- which is subject to regulatory approvals -- closes, the Journal report said.
Rite Aid spokeswoman Jody Cook declined to confirm the reports when reached Wednesday by The Associated Press. She also declined to comment. Quebec-based Jean Coutu Group declined to comment to the Journal.
The deal would add about 1,800 stores to Rite Aid's existing 3,300 locations, making Rite Aid a stronger rival to Walgreen Co. and CVS Corp. There are currently 6,171 CVS stores and 5,401 Walgreen stores, according to the companies' Web sites.
Brooks has about 330 locations in New England and New York.
Jean Coutu Group acquired the Eckerd chain in August 2004 from J.C. Penney Co. for $2.38 billion.
DNDN - Dendreon Submits Clinical and Non-Clinical Sections of Rolling BLA to FDA for PROVENGE to Treat Advanced Prostate Cancer Patients
Thursday August 24, 5:30 am ET
SEATTLE, Aug. 24 /PRNewswire-FirstCall/ -- Dendreon Corporation (Nasdaq: DNDN - News) today announced that the Company has submitted the clinical and non-clinical sections of the rolling submission of a Biologics License Application (BLA) to the U.S. Food and Drug Administration (FDA) for PROVENGE® (sipuleucel-T) for the treatment of asymptomatic patients with metastatic, androgen-independent (also known as hormone-refractory) prostate cancer. The Company plans to submit the chemistry, manufacturing and controls (CMC) section later this year, which will complete the submission of the BLA to the FDA for approval to market PROVENGE.
The clinical section of the BLA contains the evidence supporting the safety and efficacy of PROVENGE for the treatment of men with advanced prostate cancer. In particular, this section of the BLA contains the clinical trial data supporting the conclusion that PROVENGE confers an advantage in overall survival, without significant toxicity, to men with asymptomatic, metastatic, androgen-independent prostate cancer.
"Prostate cancer is the second leading cause of cancer death in American men and remains a serious unmet medical need with few effective treatment options," said Mitchell H. Gold, M.D., president and chief executive officer of Dendreon. "Based upon the results of our clinical trials, we believe that PROVENGE has a highly favorable benefit-to-risk profile, and we are focused on working closely with the FDA so that PROVENGE can be made available to help prostate cancer patients."
The FDA has granted Fast Track review status to PROVENGE enabling Dendreon to submit its BLA on a rolling basis so the FDA can review sections before receiving the complete submission. If approved, PROVENGE would become the first commercially available active immunotherapy, sometimes referred to as therapeutic cancer vaccine, to treat advanced hormone-refractory prostate cancer.
Prostate cancer is the most common non-skin cancer in the United States and the third most common cancer worldwide. More than one million men in the United States have prostate cancer, with an estimated 232,000 new cases of prostate cancer diagnosed each year. More than 30,000 men die each year of the disease.
About PROVENGE
PROVENGE (sipuleucel-T) is an investigational product that is designed to stimulate a patient's own immune system to recognize and destroy prostate cancer cells. It is currently being evaluated for the treatment of patients with early- and advanced-stage prostate cancer. In clinical studies, patients typically are randomized to receive three infusions of PROVENGE or placebo over a one-month period as a complete course of therapy.
A double-blind, placebo-controlled Phase 3 Study (D9901) published in the July 2006 issue of the Journal of Clinical Oncology found that the group of asymptomatic men with metastatic, androgen-independent prostate cancer who received PROVENGE had a median survival time 4.5 months longer than the median survival seen in the group that had been assigned to receive placebo. For the men who received PROVENGE, there was a 41 percent overall reduction in the risk of death (p-value = 0.010; HR = 1.7). In addition, 34 percent of patients receiving PROVENGE were alive 36 months after treatment compared to 11 percent of patients randomized to receive placebo.
Treatment with PROVENGE was generally well tolerated. In controlled clinical trials, the most common adverse reactions associated with PROVENGE were chills, fever, headache, fatigue, shortness of breath, vomiting and tremor. These events were primarily low grade events, with a short duration lasting 1 to 2 days following infusion.
About Active Immunotherapy
Active immunotherapy holds promise because it may provide patients with a meaningful clinical benefit, such as survival, combined with low toxicity. To develop its active immunotherapy, Dendreon utilizes proprietary technology to modify, or engineer, tumor antigens as recombinant proteins. Dendreon combines these recombinant proteins with a patient's own immune system cells so that the tumor antigens are recognized by the immune system, generating an antitumor response.
About Dendreon
Dendreon Corporation is a biotechnology company whose mission is to target cancer and transform lives through the discovery, development and commercialization of novel therapeutics that harness the immune system to fight cancer. The Company applies its expertise in antigen identification, engineering and cell processing to produce active immunotherapy product candidates designed to stimulate a cell-mediated immune response. The Company has headquarters in Seattle and is traded on The NASDAQ National Market® under the symbol DNDN. For more information about the Company and its programs, visit www.dendreon.com .
Except for historical information contained herein, this news release contains forward-looking statements that are subject to risks and uncertainties surrounding the efficacy of PROVENGE to treat men suffering from prostate cancer, risks and uncertainties surrounding the presentation of data to the FDA and approval of product applications by the FDA and risks and uncertainties inherent in the process of discovering, developing and commercializing drugs that are safe and effective for use as human therapeutics. Factors that may cause such differences include risks related to our limited operating history, risks associated with completing our clinical trials, the risk that the safety and/or efficacy results of a clinical trial for PROVENGE will not support an application for a biologics license, the risk that the FDA may interpret data differently than we do or require more data or a more rigorous analysis of data than expected, the risk that the FDA will not approve a product for which a biologics license has been applied, the risk that the results of a clinical trial for PROVENGE or other product may not be indicative of results obtained in a later clinical trial, risks that we may lack the financial resources and access to capital to fund required clinical trials or commercialization of PROVENGE, our dependence on the efforts of third parties, and our dependence on intellectual property. Further information on the factors and risks that could affect Dendreon's business, financial condition and results of operations are contained in Dendreon's public disclosure filings with the U.S. Securities and Exchange Commission, which are available at www.sec.gov .
--------------------------------------------------------------------------------
Source: Dendreon Corporation
WWEN - W2 Energy Inc. Corporate Status Report
Thursday August 24, 6:00 am ET
NEW YORK, Aug. 24, 2006 (PRIMEZONE) -- W2 Energy Inc. (Pink Sheets:WWEN) a developer of green energy, is pleased to announce a corporate status report.
In regards to the 10-SB filing the company, on advice from its attorney and auditors have decided to pursue and file a SB-2 registration instead of the Form 10-SB. The corporation's board decided that in the best interest of the company a change filing formats which will enable the corporation to execute better on its business plan in a shorter period of time. The Form 10-SB does not allow for registration of a public offering of shares and the company would have to essentially file two separate statements which would cause a delay and increase the overall cost of the transaction. Due to a large number of institutional investor interest in the company and several acquisition candidates, the corporation's board along with its attorney feel the SB-2 registration is the best course of action as this time. This decision will cause a delay in the filings because of the added paperwork.
W2 Energy continues to work on developing joint ventures and strategic alliances to further the company's business plan. The corporation is presently negotiating Memorandums of Understanding with two large North American firms to jointly build and operate 10,000 bbd plants.
The company continues to work with its partner in New Zealand to further the development of that project which was announced earlier. The project continues to move forward and management is happy with the progress.
The 100 bbd plant upgrade is moving along well and renovations have been completed to house the larger plasma unit and our own GTL design.
W2 Energy has begun work to patent several of our technologies and processes and is retaining a patent attorney to files the relevant patents on our designs and improvements on the technologies.
The management of the corporation continues to strive to build shareholder value through market awareness and have begun negotiations with selected acquisition candidates which will complement the company's arsenal of revolutionary technologies as well as immediate cash flow.
Safe Harbor for Forward-Looking Statements: Except for historical information contained herein, statements are forward-looking statements that are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. Forward-looking statements involve known and unknown risks and uncertainties, which may cause the company's actual results in the future periods to differ materially from forecasted projections. These risks and uncertainties include, among other things, energy market volatility, product demand, market competition, and risk inherent to the company's research and development operations.
Contact:
W2 Energy Inc.
(416) 246-1100
info@w2energy.com
www.w2energy.com
--------------------------------------------------------------------------------
Source: W2 Energy Inc.
WYDPF - Wyn Developments Inc. Updates on Natural Gas Projects
Thursday August 24, 12:15 am ET
VANCOUVER, BRITISH COLUMBIA--(MARKET WIRE)--Aug 24, 2006 -- Wyn Developments Inc. ("The Company") (TSX VENTURE:WL.V - News)(Other OTC:WYDPF.PK - News)(FWB: YXE) announces an update of its natural gas exploration activities, including: drilling progress on the Prophet River Slave Point exploratory well, winter development plans for the Bougie Trutch natural gas development project, and negotiations to acquire an interest in a new prospective natural gas land package.
THE PROPHET RIVER NATURAL GAS EXPLORATION PROJECT
Further to the June 23rd, 2006 news release, the Company announces that the Prophet River Slave Point exploratory well is progressing as anticipated, both on time and on budget. This well is expected to reach total depth in early September, at which time the Company will decide whether testing and completion of the well is warranted. This testing and completion would take approximately 20 days and provide a commercial evaluation of the well's potential.
THE BOUGIE TRUTCH NATURAL GAS DEVELOPMENT PROJECT
As previously reported, the two "Halfway" wells drilled in December 2005 and January 2006 at Bougie Trutch were successful, as the Operator tested and set production casing on both wells. The BC Oil and Gas Commission also confirmed that the c-36-A well proved the existence of a new gas pool. In the upcoming 2006/2007 winter season, the Company will be building upon this success by drilling two additional "Halfway" formation delineation wells near the original C-36-A well. If successful, these three wells should be tied-in for production by March 2007.
THE TRUTCH EAST NEGOTIATIONS
The Company is also currently in negotiations to acquire an interest in a rolling option for up to 15 square miles of prospective natural gas leases adjoining the South and Southeast portions of the Company's Bougie Trutch development project. 2D and 3D seismic has been completed on the property and further details will be provided upon successful completion of the negotiations.
For more information, please visit the Company's website at www.wyndevelopments.ca.
On Behalf of the Board,
WYN DEVELOPMENTS INC.
David McMillan, President & CEO
FORWARD-LOOKING STATEMENTS
This press release may contain forward-looking statements including expectations of future production. More particularly, this press release contains statements concerning Wyn Developments Inc. future production estimates, expansion of oil and gas property interests, exploration and development drilling, regulatory applications, payout estimates, capital expenditures, and drilling locations to be drilled in 2006. These statements are based on current expectations that involve a number of risks and uncertainties, which could cause actual results to differ from those anticipated. These risks include, but are not limited to: the risks associated with the oil and gas industry (e.g., operational risks in development, exploration and production; delays or changes in plans with respect to exploration or development projects or capital expenditures; the uncertainty of reserve estimates; the uncertainty of estimates and projections relating to production, costs and expenses, and health, safety and environmental risks), commodity price, price and exchange rate fluctuation and uncertainties resulting from potential delays or changes in plans with respect to exploration or development projects or capital expenditures. Additional information on these and other factors that could affect Wyn's operations or financial results are included in Wyn Development's reports on file with Canadian securities regulatory authorities. The forward-looking statements or information contained in this news release are made as of the date hereof and Wyn Developments undertakes no obligation to update publicly or revise any forward-looking statements or information, whether as a result of new information, future events or otherwise, unless so required by applicable securities laws. Oil and Gas Advisory. This press release contains disclosure expressed as "Boe/d". All oil and natural gas equivalency volumes have been derived using the ratio of six thousand cubic feet of natural gas to one barrel of oil. Equivalency measures may be misleading, particularly if used in isolation. A conversion ratio of six thousand cubic feet of natural gas to one barrel of oil is based on an energy equivalency conversion method primarily applicable at the burner tip and does not represent a value equivalency at the well head.
The TSX Venture Exchange has not reviewed and does not accept responsibility for the adequacy or accuracy of this release.
Contact:
Contacts:
Wyn Developments Inc. - Head Office
Tom Brady
(604) 685-5851 or Toll Free: 1-888-685-5851
Wyn Developments Inc. - Head Office
Chad McMillan
(604) 685-5851 or Toll Free: 1-888-685-5851
Wyn Developments Inc. - Head Office
Dave McMillan
(604) 685-5851 or Toll Free: 1-888-685-5851
(604) 685-7349 (FAX)
ir@urg.ca
Wyn Developments Inc.
Arthur Ferjo
(705) 743-5042
arthur@urg.ca
http://www.wyndevelopments.ca
Small Cap Invest Ltd. - Europe
Alexander Friedrich
49 (0) 69-24 24 93 49
49 (0) 12 12 544 71 04 62
afriedrich@small-cap-invest.com
Yes International Inc. - United States
Rich Kaiser
(757) 306-6090 or 1-800-631-8127
(757) 306-6092 (FAX)
rich@yesinternational.com
--------------------------------------------------------------------------------
Source: Wyn Developments Inc.
Conversion Solutions Holdings Corp Updates Shareholders and Files 8K on Current Events
Thursday August 24, 12:03 am ET
KENNESAW, Ga., Aug. 23 /PRNewswire-FirstCall/ -- Conversion Solutions Holdings Corp (OTC Bulletin Board: CSHD - News), a Delaware Corporation announces that during the 10-K filing process the following current events have taken place.
CSHD would like to announce the additional Deposit from the Humanitarian & Scientific World Foundation, LTD a Georgia LTD Foundation.
The Annex to the Global Funding Agreement brings a 749 Million Euro denominated Bond on the Republic of Finland with a 6% coupon to CSHD's Asset Back Management facility. (The Bond holds an S&P, Fitch, and Composite AAA rating).
The bond is loaded in the systems with the following codes:
Republic of Finland 6% AAA
Common Code: 008120510
ISIN: FI0001004558
Copy and paste the following link into a browser to see 8K file:
http://sec.gov/cgi-bin/browse-
edgar?company=furia&CIK=&filenum=&state=&sic=&owner=include&action=getcompany
About Conversion Solutions Holdings Corp
CSHD is a diversified holdings corporation, which was formed to originate, fund and source funding for asset-based transactions in the private market. CSHD's main service will be to acquire, fund and provide insurance to target companies in the currently underserved $15,000,000 to $100,000,000 asset finance market. Our funding will enable our businesses to compete more effectively, improve operations and increase value. CSHD is headquartered in Kennesaw, Georgia, a suburb of Atlanta. For more information, please visit us at http://www.cvsu.us.
--------------------------------------------------------------------------------
Source: Conversion Solutions Holdings Corp
CSHD - Conversion Solutions Holdings Corp Updates Shareholders and Files 8K on Current Events
Thursday August 24, 12:03 am ET
KENNESAW, Ga., Aug. 23 /PRNewswire-FirstCall/ -- Conversion Solutions Holdings Corp (OTC Bulletin Board: CSHD - News), a Delaware Corporation announces that during the 10-K filing process the following current events have taken place.
CSHD would like to announce the additional Deposit from the Humanitarian & Scientific World Foundation, LTD a Georgia LTD Foundation.
The Annex to the Global Funding Agreement brings a 749 Million Euro denominated Bond on the Republic of Finland with a 6% coupon to CSHD's Asset Back Management facility. (The Bond holds an S&P, Fitch, and Composite AAA rating).
The bond is loaded in the systems with the following codes:
Republic of Finland 6% AAA
Common Code: 008120510
ISIN: FI0001004558
Copy and paste the following link into a browser to see 8K file:
http://sec.gov/cgi-bin/browse-
edgar?company=furia&CIK=&filenum=&state=&sic=&owner=include&action=getcompany
About Conversion Solutions Holdings Corp
CSHD is a diversified holdings corporation, which was formed to originate, fund and source funding for asset-based transactions in the private market. CSHD's main service will be to acquire, fund and provide insurance to target companies in the currently underserved $15,000,000 to $100,000,000 asset finance market. Our funding will enable our businesses to compete more effectively, improve operations and increase value. CSHD is headquartered in Kennesaw, Georgia, a suburb of Atlanta. For more information, please visit us at http://www.cvsu.us.
--------------------------------------------------------------------------------
Source: Conversion Solutions Holdings Corp
LNVGF - Lenovo Launches New Services Unit; Names Christopher J. Askew as SVP, Lenovo Services
Thursday August 24, 5:00 am ET
HONG KONG, August 24 /CNW/ - Lenovo Group today announced a new Lenovo Services business unit, uniting all aspects of customer service globally under the leadership of a new senior executive, Christopher J. Askew.
"Customer satisfaction is a key goal for Lenovo, and this new Lenovo Services unit deepens our commitment to delighting customers with every services engagement," said William J. Amelio, Lenovo's chief executive officer. "Services are increasingly important to all PC customers, and we intend to take our responsiveness and performance to industry-leading levels. While Lenovo already approaches best-of-breed in this respect, services leadership requires a strong, unified global organization to drive both the highest customer satisfaction and operational excellence."
Christopher J. Askew, 44, has been appointed to lead the new organization as senior vice president, Lenovo Services, effective immediately. He will report directly to Mr. Amelio and will be based in Singapore.
"Chris is a high-energy executive with critical strategic, financial and operating skills. His track record includes proven results, consistently exceeding financial and operating targets in start-up, turnaround and high-growth environments," Mr. Amelio added. "He brings to Lenovo global experience from the US, EMEA and AP, as well as in both direct- and channel-driven strategies."
Most recently, Mr. Askew served as vice president, Dell Services, Asia-Pacific and Japan. Mr. Askew joined Dell in 1999, and was the senior executive responsible for all elements of Dell's Asia-Pacific and Japan services business across 38 countries. His responsibilities included Services sales and marketing, Professional Services, Managed Services, Field Service delivery and logistics, and Technical Support. Under Mr. Askew's leadership, Dell's AP&J Services revenue grew substantially and the unit became a major profit contributor to the overall business.
Prior to joining Dell, Mr. Askew held senior positions with Compaq Computer and Tandem Computers. At Compaq, his positions included responsibility for all services business elements in the Western Region of the US, and also direction of customer services in Asia-Pacific and Japan. With Tandem, he worked for the Tandem Consulting Integration and Services unit in Asia, and also in the European division. Mr. Askew began his career at the Bank of England in various technical and operations management positions.
"Lenovo has enormous opportunities with services, not only to delight our customers, but also to grow our overall business. Chris will work to create a powerful Lenovo Services brand that differentiates Lenovo in the market via exceptional service delivery and value," Mr. Amelio said.
About Lenovo Group Ltd.
Lenovo (HKSE: 992) (ADR: LNVGY) is dedicated to building the world's most innovative personal computers. Lenovo's business model is built on innovation, operational efficiency and customer satisfaction as well as a focus on investment in emerging markets. Formed by Lenovo Group's acquisition of the former IBM Personal Computing Division, the company develops, manufactures and markets reliable, high-quality, secure, and easy-to-use technology products and services worldwide. For more information, see www.lenovo.com.
For further information
Lenovo Group Ltd. New York: Carol Makovich, 914-701-2811 makovich@us.lenovo.com or Hong Kong: Angela Lee, 852-2516-4810 angelalee@lenovo.com or Beijing: Jean Cai, 8610-5886-8912 caixqb@lenovo.com
--------------------------------------------------------------------------------
Source: Lenovo Group Ltd.
UTYW - Unity Wireless Receives US$275,000 Purchase Orders From WiMax Network OEM Customer
Thursday August 24, 5:45 am ET
BURNABY, BC--(MARKET WIRE)--Aug 24, 2006 -- Unity Wireless Corporation (OTC BB:UTYW.OB - News), a developer of wireless systems and coverage-enhancement solutions, has received a purchase order worth approximately US$275,000 from an existing OEM customer for the immediate supply of power amplifiers.
The product, a 4 Watt power amplifier for use in 3.5 GHz WiMax-ready OFDM base stations, was previously qualified by the customer and is a field-proven performer with thousands deployed in broadband wireless networks worldwide.
This purchase order is a release under a US$770,000 order originally announced January 18, 2006.
About Unity Wireless
Unity Wireless is a developer of wireless systems and coverage-enhancement solutions for wireless communications networks. For more information about Unity Wireless, visit www.unitywireless.com.
Contact:
Investor Contact:
James Carbonara
The Investor Relations Group
(212) 825-3210
Mike Mulshine
Osprey Partners
(732) 292-0982
osprey57@optonline.net
--------------------------------------------------------------------------------
Source: Unity Wireless Corp.
bob, you forgot to add "IMO" to that.
Speaking of getting cranky...
Lets cut out the personal attacks.
Personal Attack – when someone attacks a person, with name calling, or relating to the messenger and not the message.
Guide for Stock-Specific and Free Zone Board Moderators
(These boards can be posted on by any registered free or paid member of the site.)
Note: When managing one of these boards, you have six reasons to choose from when deciding whether or not a post should be removed:
Duplicate – an accidental duplicate post by a member
Personal Attack – when someone attacks a person, with name calling, or relating to the messenger and not the message.
Spam – a message that is being posted promoting other sites, stock-related or not, that has no use in the discussion (for example, if your board is about Ford Motors, a link promoting amazing returns running a home-based business is worthless to the discussion).
Vulgarity – cursing of any kind unacceptable on your board
Violation of Privacy – posting of any personal identifiable information (email, real name, phone, address, etc)
Threat – someone threatening another member in some fashion
US
and the day? I say by turkeyday
We should start taking bets on the next R/S for them, whatcha think?
"10-for-1 Warrant Shares Exercised are Exempt from the Split"
ughhh what a P O S
I am shocked...NOT
CTIC - Paclitaxel Poliglumex (XYOTAX(TM)) and Concurrent Radiation Produces Major Tumor Responses in 91 Percent of Patients With Esophageal or Gastric Cancer
Wednesday August 23, 7:00 am ET
Phase I Data Published in August Issue of American Journal of Clinical Oncology
SEATTLE, Aug. 23 /PRNewswire-FirstCall/ -- Cell Therapeutics, Inc. (CTI) (Nasdaq: CTIC; MTAX: CTIC) today announced that data from a phase I study of weekly XYOTAX given in combination with radiation for patients with esophageal or gastric cancer was published in the August edition of the American Journal of Clinical Oncology. Twenty-one patients were treated to evaluate the safety of the regimen and to determine the maximum tolerated dose of XYOTAX in combination with 50.4 Gy concurrent radiation. Of the 12 patients with loco-regional disease in whom tumor responses were evaluated, four patients (33 percent) achieved a complete response and seven patients (58 percent) achieved a partial response (50 percent or greater shrinkage of their tumor), for an overall objective response rate of 91 percent.
"XYOTAX is an important new radiation sensitizer in esophageal cancer. Preclinically, XYOTAX is a much more potent radiation sensitizer than paclitaxel," stated Howard Safran, M.D., of Brown University and principal investigator on the study. "XYOTAX may replace paclitaxel as the most important radiation sensitizer in solid tumors."
At the maximum tolerated dose of 70 mg/m2/week given for six weeks, one patient had grade 3 esophagitis. There were no grade 3/4 toxicities at dose levels below 70 mg/m2/week. At the 80mg/m2 dose level three of four patients had dose limiting toxicities including grade 3 esophagitis/gastritis (2 patients), grade 3 dehydration (1 patient), and grade 4 neutropenia (1 patient). Except for the four patients who experienced dose limiting toxicity, all patients completed the full six weeks of concurrent chemoradiation.
"The safety profile of XYOTAX and its protocol-defined dose with standard course radiation coupled with its impressive anti-tumor activity provide clinical support for preclinical studies demonstrating its great potency as a radiosensitizer," stated Jack W. Singer, Chief Medical Officer of CTI. "A follow-on study in combination with cisplatin and radiation is currently in progress."
About the Study
The objective of the study was to determine the maximum tolerated dose and dose limiting toxicities of weekly XYOTAX in combination with 50.4 Gy concurrent radiation in patients with esophageal or gastric cancer. Twenty-one patients were treated with five dose levels of XYOTAX of 40 mg/m2 (three patients), 50 mg/m2 (four patients), 60 mg/m2 (four patients), 70 mg/m2 (six patients) and 80 mg/m2 (four patients). Sixteen patients had esophageal cancer and five had gastric cancer. Preliminary data on this study was presented at the 2005 meeting of the American Society of Clinical Oncology (ASCO).
For more information about this article or about our clinical trials, please visit our website: www.cticseattle.com .
About XYOTAX
XYOTAX(TM) (paclitaxel poliglumex) is a biologically-enhanced chemotherapeutic that links paclitaxel, the active ingredient in Taxol®, to a biodegradable polyglutamate polymer, which results in a new chemical entity. When bound to the polymer, the chemotherapy is rendered inactive, potentially sparing normal tissue's exposure to high levels of unbound, active chemotherapy and its associated toxicities. Blood vessels in tumor tissue, unlike blood vessels in normal tissue, are porous to molecules like polyglutamate. Based on preclinical studies, it appears that XYOTAX is preferentially distributed to tumors due to their leaky blood vessels and trapped in the tumor bed allowing significantly more of the dose of chemotherapy to localize in the tumor than with standard paclitaxel. Once inside the tumor cell, enzymes metabolize the protein polymer, releasing the paclitaxel chemotherapy. Preclinical and clinical studies support that XYOTAX metabolism by lung cancer cells may be influenced by estrogen, which could lead to enhanced release of paclitaxel and efficacy in women with lung cancer compared to standard therapies.
About Cell Therapeutics, Inc.
Headquartered in Seattle, CTI is a biopharmaceutical company committed to developing an integrated portfolio of oncology products aimed at making cancer more treatable. For additional information, please visit www.cticseattle.com .
This press release includes forward-looking statements that involve a number of risks and uncertainties, the outcome of which could materially and/or adversely affect actual future results. Specifically, the risks and uncertainties that could affect the development of XYOTAX include risks associated with preclinical and clinical developments in the biopharmaceutical industry in general and with XYOTAX in particular including, without limitation, the potential failure of XYOTAX to prove safe and effective for treatment of esophageal and gastric cancers, determinations by regulatory, patent and administrative governmental authorities, competitive factors, technological developments, costs of developing, producing and selling XYOTAX, and the risk factors listed or described from time to time in the Company's filings with the Securities and Exchange Commission including, without limitation, the Company's most recent filings on Forms 10-K, 8-K, and 10-Q. Pursuant to U.S. law, CTI is under no obligation to (and expressly disclaims any such obligation to) update or alter its forward-looking statements whether as a result of new information, future events, or otherwise.
--------------------------------------------------------------------------------
Source: Cell Therapeutics, Inc.
Stock futures slip ahead of housing data
Wednesday August 23, 8:18 am ET
By Caroline Valetkevitch
NEW YORK (Reuters) - U.S. stock index futures dipped on Wednesday before data on the housing market that could point to further weakness in that sector.
A reduced quarterly revenue forecast from National Semiconductor Corp. (NYSE:NSM - News), which makes chips that control power consumption in electronics, could give a negative tone to the chip sector. Its shares slid 2.4 percent after the bell on Tuesday, dragging down the stock of rival Texas Instruments Inc. (NYSE:TXN - News).
The National Association of Realtors will release existing home sales for July at 10 a.m. Economists in a Reuters survey forecast a median 6.55 million annualized units total versus 6.62 million annualized units in June.
"We're probably going to get a negative read on the housing market. Estimates are for new home sales to be lower," said Arthur Hogan, chief market analyst at Jefferies & Co. "Now that we've seen the Fed pass once on tightening, we'd like to see less inflationary data but certainly benign data as it pertains to the pace of the U.S. economy."
S&P 500 futures (SPc1) were down 1.80 points, slightly below fair value, a mathematical formula that evaluates pricing by taking into account interest rates, dividends and time to expiration on the contract.
Dow Jones industrial average futures (DJc1) were down 12 points and Nasdaq 100 (NDc1) futures were down 2 points.
The Federal Reserve kept interest rates steady at its last policy-setting meeting after more than two years of raising rates.
On Tuesday, luxury home builder Toll Brothers Inc.'s (NYSE:TOL - News) chief executive talked of a "continuing malaise" damping buyer sentiment.
In deal news, IBM (NYSE:IBM - News), the world's largest information-technology company, on Wednesday said it agreed to buy Internet Security Systems Inc. (NASDAQ:ISSX - News) for $1.3 billion.
Crude oil prices slipped below $73 a barrel as world powers studied Iran's offer of more talks to resolve a nuclear dispute that could lead to sanctions against the fourth largest oil exporter. U.S. crude (CLc1) for October delivery was 59 cents lower at $72.51, after falling 20 cents on Tuesday.
A government report on U.S. petroleum supply on Wednesday is expected to show crude inventories fell last week as refinery runs held steady while supplies in the West Coast began to show the effects of a partial outage in Alaska's Prudhoe Bay production.
Shares of medical device maker Medtronic Inc. (NYSE:MDT - News) rose 2.1 percent after the bell on Tuesday after it reported higher quarterly earnings.
Also, shares of book retailer Borders Group Inc. (NYSE:BGP - News) fell after the bell after the company reported quarterly results that swung to a loss compared to a year-ago profit. Borders' shares fell to $19.08 on the Inet electronic brokerage system from a close at $20.26 on the NYSE.
In other corporate news, tax-preparation and business software maker Intuit Inc. (NASDAQ:INTU - News) posted a smaller-than-expected loss in its typically weak fourth quarter.
TI shares declined 2.1 percent to $31.81 after the bell, while National Semiconductor shares slid to $22.01.
NSOL - Nuclear Solutions, Inc. Announces Waste-to-Energy Hybrid Approach to Bioethanol Production
Tuesday August 22, 4:05 pm ET
Company Launches Liquidyne Fuels, Inc. to Produce Virtually Fossil-Free Ethanol
WASHINGTON, DC--(MARKET WIRE)--Aug 22, 2006 -- As reported in its most recently filed 10Q-SB report on August 21, 2006, Nuclear Solutions, Inc. (OTC BB:NSOL.OB - News) has launched Liquidyne Fuels, Inc., to establish multiple bioethanol plants using Startech Environmental Corporation's Plasma Converter technology as part of a waste-to-energy hybrid approach for bioethanol production. The Liquidyne Fuels business model virtually eliminates the use of fossil fuels such as natural gas and coal that are normally consumed during the production of conventional fermentation-based ethanol.
This approach to bioethanol production is being pursued concurrently and in conjunction with Nuclear Solutions' and Fuel Frontiers' ongoing plans for waste-to-ethanol synthesis facilities. Liquidyne Fuels intends to locate new bioethanol production facilities domestically and internationally, with initial focus on the east and west coasts of the United States.
In tandem with ethanol synthesis from waste sources, Nuclear Solutions now intends to use a waste-to-energy hybrid approach to dry-mill bioethanol production that would employ Plasma Converters supplied by Startech Environmental Corporation to accomplish the virtual elimination of fossil fuels in the production cycle. This approach to bioethanol production will be executed by Liquidyne Fuels, Inc.
Nuclear Solutions, Inc. President and CEO Patrick Herda explains: "We are pleased to unveil this next phase of our strategy in the ethanol business. Burning fossil fuels for the production of ethanol is old-school and counterintuitive when producing an environmentally friendly fuel additive. We intend to produce a more environmentally conscious brand of ethanol, which is why we plan on doing this fossil-free.
"As our business model reflects, we believe at least two promising avenues are attractive and complementary for the production of ethanol. One of the ways we are pursuing is the synthesis of ethanol from wastes that led to the formation of our subsidiary Fuel Frontiers. The other way is to apply new innovations to more conventional approaches in order to overcome existing limitations and some of the barriers that previously limited the worthwhile production of ethanol within key geographic markets.
"We believe the combination of these two symbiotic approaches makes economic sense and helps position us to fulfill our goal of maximizing ethanol production to meet the ever-increasing demand for fuel."
Nuclear Solutions, Inc. is an innovative technology development company committed to exploring, developing, and commercializing viable products in the areas of nanotechnology, environmental technology, homeland security and defense, and, most recently, alternative fuels. In August 2005, Nuclear Solutions, Inc. established Fuel Frontiers, Inc. (FFI), a subsidiary implementing its own unique business model to utilize commercially available and proprietary technologies to transform low-value, end-of-life carbonaceous waste materials such as waste coal, used tires, wood wastes, biomass, discarded corn stalks and other agricultural by-products, into high-value, environmentally friendly, clean-burning ethanol. With its global Strategic Alliance Agreement with Connecticut-based Startech Environmental Corporation, FFI gains access to Startech's innovative, proven and proprietary Plasma Converter(TM) System, which is proposed for use in planned facilities to transform feedstock materials into ethanol. To diversify its ethanol production model beyond ethanol synthesis from waste sources, Nuclear Solutions is also pursuing innovations in bioethanol production through its subsidiary Liquidyne Fuels, Inc. Currently, Fuel Frontiers, Inc. and Liquidyne Fuels, Inc. report their operations and financial results on a consolidated basis within Nuclear Solutions, Inc.'s public filings. To learn more, explore www.nuclearsolutions.com or www.fuelfrontiers.com.
DISCLAIMER
The matters discussed in this press release are forward-looking statements that involve a number of risks and uncertainties such as our plans, objectives, expectations, and intentions. You can identify these forward-looking statements by our use of words such as "pursue," "plans," "intends to locate," "initial focus," "virtually eliminate," "next phase," "intend," "believe," "that can be," "helps position," "by launching," "also pursuing," "proposed for use," "is also pursuing" or other similar words or phrases. Some of these statements include discussions regarding our future business strategy and our ability to generate revenue, income and cash flow.
With regards to forward-looking statements on the proposed waste-to-ethanol facility, a facility like this has never before been constructed or operated and there are inherent risks associated with the establishment of such new operations. There could be unexpected problems or delays in the funding, construction and operation of the facility. There is no guarantee that we will be successful in raising the capital required for this project through the issuance of tax-free bonds discussed herein. While we believe that the appropriate technologies for waste-to-ethanol conversion are commercially available, we cannot guarantee that commercially available technologies will be suitable for producing ethanol in the proposed Fuel Frontiers, Inc. facility.
Overall, actual future results for Nuclear Solutions, Inc., and its subsidiary Fuel Frontiers, Inc., could differ significantly from statements contained in the press release. Factors that could adversely affect actual results and performance include, among others, the companies' limited operating history, dependence on key management, financing requirements, technical difficulties commercializing any projects, government regulation, technological change, and competition. In any event, undue reliance should not be placed on any forward-looking statements, which apply only as of the date of this press release. Additionally, patent pending status or licensing does not guarantee that a patent will issue or that the technology will be commercially successful. Accordingly, reference should be made to Nuclear Solutions, Inc.'s periodic filings with the U.S. Securities and Exchange Commission, also available through the web site at www.nuclearsolutions.com.
Contact:
Contact:
Investor Relations
202-580-8330
--------------------------------------------------------------------------------
Source: Nuclear Solutions, Inc.
INTZ - Intrusion Inc. Receives $340,000 Order
Tuesday August 22, 4:05 pm ET
RICHARDSON, Texas, Aug. 22 /PRNewswire-FirstCall/ -- Intrusion Inc. (Nasdaq: INTZ - News), ("Intrusion") announced today it received an order for $340,000 from a U.S. Defense Contractor for an additional TraceCop project. TraceCop is the Company's product that provides unprecedented abilities to trace the source of cyber based attacks and other types of network crime. This new order brings the total to $2,390,000 of orders received this year for TraceCop: $300,000 in the first quarter, $1,500,000 in the second quarter, $250,000 earlier in the third quarter and the current $340,000 order announced today.
About Intrusion Inc.
Intrusion Inc. is a global provider of regulated information compliance, entity identification systems, data privacy protection products, and network intrusion prevention and detection solutions. Intrusion's product families include the Compliance Commander(TM) for regulated information compliance, data privacy protection and identity theft prevention, TraceCop(TM) identification and location system, Intrusion SpySnare(TM) for real-time inline blocking of spyware and unwanted P2P applications, and Intrusion SecureNet(TM) for network intrusion prevention and detection. Intrusion's products help protect critical information assets by quickly detecting, protecting, analyzing and reporting attacks or misuse of classified, private and regulated information for government and enterprise networks. For more information, please visit www.intrusion.com .
This release, other than historical information, may include forward- looking statements regarding future events or the future financial performance of the Company. These statements are made under the "safe harbor" provisions of the Private Securities Litigation Reform Act of 1995 and involve risks and uncertainties which could cause actual results to differ materially from those in the forward-looking statements, including but not limited to the following: the difficulties in forecasting future sales caused by current economic and market conditions, the effect of military actions on government and corporate spending on information security products, spending patterns of, and appropriations to, U.S. government departments, the impact of our cost reduction programs and our refocused product line, the difficulties and uncertainties in successfully developing and introducing new products in emerging markets, market acceptance of our products, the impact of our sustained losses on our ability to successfully operate and grow our business, our stock price and our ongoing Nasdaq eligibility, our ability to generate sufficient cash flow or obtain additional financing on acceptable terms in order to fund ongoing liquidity needs, the highly competitive market for our products, the effects of sales and implementation cycles for our products on our quarterly results, difficulties in accurately estimating market growth, the consolidation of the information security industry, our ability to expand revenues through indirect sales channels, the impact of changing economic conditions, business conditions in the information security industry, our ability to manage acquisitions effectively, our ability to manage discontinued operations effectively, the impact of market peers and their products as well as risks concerning future technology and others identified in our Annual Report on Form 10-KSB, as amended, and other Securities and Exchange Commission filings. These filings can be obtained by contacting Intrusion Investor Relations.
Financial Contact
Michael L. Paxton, VP, CFO
972.301.3658, mpaxton@intrusion.com
Media Contact
Jay Barbour, Vice President of Marketing
972.664.8107, jbarbour@intrusion.com
--------------------------------------------------------------------------------
Source: Intrusion Inc.
SYNX - Synergx Systems Inc. Announces New $2.5 Million Contract
Tuesday August 22, 4:15 pm ET
SYOSSET, N.Y., Aug. 22 /PRNewswire-FirstCall/ -- Synergx Systems Inc. announces that it has secured a new order for approximately $2.5 million dollars to provide various electronic systems for the New York City Transit Authority in lower Manhattan. The securing of this order is the direct result of the reorganization and new marketing approach of our transit group.
Synergx is engaged in the design, manufacture, marketing and service of a variety of data communication products and systems with applications in the fire alarm, life safety, security and communication industries. For further information about Synergx please go to our website at WWW.SYNERGXSYSTEMS.COM
"Safe Harbor" statement under the Private Securities Reform Act of 1995: This release contains forward-looking statements, which reflect management's current views of future events and operations. These forward-looking statements are based on assumptions and external factors, including assumptions relating to product pricing, competitive market conditions, financial data, and other risks or uncertainties detailed from time to time in the Company's filings with the Securities and Exchange Commission. These forward-looking statements represent the Company's judgment as of the date of this release and any changes in the assumptions of external factors could produce significantly different results.
--------------------------------------------------------------------------------
Source: Synergx Systems Inc.
EXPH - Expo Holdings, Inc. Receives Large Order From No. 2 Home Improvement Retailer, Lowe's Companies, Inc.
Tuesday August 22, 4:57 pm ET
NORTH WILKESBORO, N.C., Aug. 22, 2006 (PRIMEZONE) -- Expo Holdings, Inc., (Other OTC:EXPH.PK - News), through its wholly owned subsidiary D&D Displays, Inc., received a large order from Lowe's Companies, Inc. The order totaled over $185,000.
According to J.D. Brown, Chairman and CEO of Expo Holdings, Inc., ``We are very pleased that our relationship with this retailer continues to grow.'' He further stated, ``This order should ship within the next 30 to 90 days in its entirety.''
Expo Holdings, Inc., through its wholly owned subsidiary D&D Displays, Inc., designs, manufacturers and distributes retail store displays.
Certain information contained in these materials is ``forward-looking'' information, such as estimates, expectations or plans. All forward-looking information is subject to known and unknown risks and uncertainties. Consequently, actual results may, and probably will differ.
Contact:
Expo Holdings, Inc., North Wilkesboro, N.C.
J.D. Brown, Chairman and CEO
336-667-8765
--------------------------------------------------------------------------------
Source: Expo Holdings, Inc.
Coalition for Fair Lumber Imports Comments on Canadian Government Confirmation That It Will Implement Lumber Settlement Agreement
Tuesday August 22, 5:27 pm ET
WASHINGTON, Aug. 22 /CNW/ -- The Coalition for Fair Lumber Imports welcomes the Canadian government's confirmation that it plans to sign and implement by October 1 the lumber settlement agreement initialed on July 1. This confirmation is based on statements of support by a broad group of Canadian lumber producers.
Mr. Swanson stated that, "the U.S. lumber industry continues to have significant concerns about certain aspects of the agreement, but nonetheless supports the initiative of both governments to settle this dispute."
Swanson concluded by stating that the U.S. industry "applauds the leadership of President Bush, and the skill and dedication of USTR Ambassador Susan Schwab and USTR General Counsel Jim Mendenhall in making this agreement a reality."
About the Coalition for Fair Lumber Imports
The U.S. Coalition for Fair Lumber Imports is an alliance of large and small lumber producers from around the country, joined by hundreds of thousands of their employees, and tens of thousands of woodland owners. The Coalition is united in opposition to Canada's unfair lumber-trade practices, including its gross under-pricing of timber. For more information, please visit the Coalition's website at http://www.fairlumbercoalition.org.
For further information
Zoltan van Heyningen, +1-202-862-3686, for Coalition for Fair Lumber Imports, Web Site: http://www.fairlumbercoalition.org
--------------------------------------------------------------------------------
Source: Coalition for Fair Lumber Imports
YMI - YM BioSciences announces independent Data Safety Monitoring Board recommends tesmilifene pivotal trial continue as planned
Tuesday August 22, 5:46 pm ET
MISSISSAUGA, ON, Aug. 22 /PRNewswire-FirstCall/ - YM BioSciences Inc. (AMEX:YMI, TSX:YM, AIM:YMBA), a company engaged in the acquisition, development and commercialization of oncology and acute care products, today announced that the independent Data Safety Monitoring Board (DSMB) for the pivotal Phase III trial of tesmilifene in metastatic and recurrent breast cancer has completed its second planned safety and efficacy analysis following 256 events and concluded that the trial should continue as planned.
"We are encouraged by the DSMB's conclusion that our pivotal Phase III trial should proceed," said David Allan, Chairman and CEO of YM BioSciences. "Based on the study design, we believe the trial continues to have the prospect to yield a positive outcome. Further, this analysis also confirms that tesmilifene continues to demonstrate a good safety profile."
The pivotal Phase III trial compares the survival of patients treated with tesmilifene combined with epirubicin/cyclophosphamide to epirubicin/cyclophosphamide alone in women with rapidly progressing metastatic and/or recurrent breast cancer. The trial, which completed enrollment of 723 patients in September 2005, is the subject of a Special Protocol Assessment and a Fast Track designation for advanced breast cancer by the FDA.
The trial is being conducted according to a sequential design that permits a number of analyses and the trial will continue until one of two specific statistical conditions is satisfied. At each analysis, the hazard ratio between the tesmilifene-containing treatment arm and the control arm is calculated and then reviewed by the DSMB, and the trial may be concluded if either the tesmilifene-containing treatment arm is superior to the control by a specified margin or it is determined that such evidence is not going to be found. If the evidence is insufficient for either conclusion to be drawn, then the trial continues until the next analysis. The third analysis is expected to occur in Q3/Q4 2006 although, based on the data available to date, it is not possible to determine exactly when it will occur nor do the available data permit an accurate prediction of the outcome of the trial.
About YM BioSciences
YM BioSciences Inc. is engaged in the acquisition, development and commercialization of oncology and acute care products.
Tesmilifene is a small molecule MDR-targeting agent that is being tested in combination with various standard chemotherapy regimens for the treatment of a number of cancers. In addition to the Phase III DEC trial combining tesmilifene with an anthracycline a collaborative trial with Sanofi-Aventis is currently ongoing combining tesmilifene with Taxotere® (docetaxel) a taxane drug. A trial combining tesmilifene with epirubicin, cyclophosphamide, and 5-FU is anticipated for the treatment of gastric cancer and additional trials are in planning.
In addition, YM BioSciences is developing nimotuzumab, AeroLEF(TM) and Norelin.
Nimotuzumab is an anti-EGFR humanized antibody that was recently partnered in Japan with Daiichi Pharmaceutical Co., Ltd. Nimotuzumab was approved in India in July 2006 for the treatment of head & neck cancer, is currently in a Phase I/II trial in a specific population of patients with non-small cell lung cancer in Canada and a Phase IIl trial in Europe in combination with radiation for the treatment of pediatric pontine glioma.
AeroLEF(TM) is a unique inhaled-delivery composition of free and liposome encapsulated fentanyl, for the treatment of moderate to severe acute pain, including cancer pain. AeroLEF(TM) is currently enrolling post-surgical patients in a randomized Phase IIb trial.
Norelin, an anti-cancer vaccine, stimulates the immune system to develop antibodies to gonadotropin-releasing hormone (GnRH). In addition, YM BioSciences also owns a portfolio of pre-clinical compounds
Except for historical information, this press release may contain forward-looking statements, which reflect the Company's current expectation regarding future events. These forward-looking statements involve risk and uncertainties, which may cause but are not limited to, changing market conditions, the successful and timely completion of clinical studies, the establishment of corporate alliances, the impact of competitive products and pricing, new product development, uncertainties related to the regulatory approval process and other risks detailed from time to time in the Company's ongoing quarterly and annual reporting.
--------------------------------------------------------------------------------
Source: YM BioSciences Inc.
This says alot...
Posted by: chiphldr
In reply to: PowerPole who wrote msg# 49557 Date:8/21/2006 11:27:08 AM
Post #of 52370
Just got off the phone with Paul in IR for SLJB and they have been working with Vista Group International for awhile now....He also mentioned they had done some work recently with Wessal Group as well....
I believe these guys are professional asset and money managers that are kinda new to the ir/pr but not to managing money both here in the USA and in the Midlle East>> HENCE the reason Vista Group just had them all UNITE and form the new Corp... Marquee Asset Mgnt...
OK so "had done some work recently with Wessal Group"
is this the group that will be purchasing shares for Wessal?